Interrelationship of Circulating Matrix Metalloproteinase-9, TNF-α, and OPG/RANK/RANKL Systems in COPD Patients with Osteoporosis

By Zhang Pei-fang   Pan Lei   Luo Zhi-yang   Zhao Hai-jin   Cai Shao-xi  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 10, Iss. 6, 2013-12 ,pp. : 650-656

Informa Healthcare

Access to resources Recommend Favorite

Overexpression of Matrix Metalloproteinase-21 is Associated with Poor Overall Survival of Patients with Colorectal Cancer

By Huang Yi  

Journal of Gastrointestinal Surgery, Vol. 15, Iss. 7, 2011-07 ,pp. : 1188-1194

Springer Publishing Company

Access to resources Recommend Favorite

Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNFα inhibitors

By Pedersen Susanne   Hetland Merete   Sørensen Inge   Østergaard Mikkel   Nielsen Hans   Johansen Julia  

Clinical Rheumatology, Vol. 29, Iss. 11, 2010-11 ,pp. : 1301-1309

Springer Publishing Company

Access to resources Recommend Favorite

Circulating Matrix Metalloproteinase-9 Level Is Associated with Cerebral White Matter Hyperintensities in Non-Stroke Individuals

By  

European Neurology, Vol. 72, Iss. 3-4, 2014-09 ,pp. : 234-240

Karger

Access to resources Recommend Favorite

Matrix Metalloproteinase-2, -9 and Tissue Inhibitor Metalloproteinase-1 in Patients with Hypertension Before and After Doxazosin Therapy

By Derosa Giuseppe  

High Blood Pressure & Cardiovascular Prevention, Vol. 13, Iss. 2, 2006-01 ,pp. : 47-52

Adis International

Access to resources Recommend Favorite